Craig Underhill

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Andrew Webb, David Cunningham, J.H. Scarffe et al. · Journal of Clinical Oncology · 1997 · 873 citations

Medicine, Oncology, Pharmacology +15

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

Stephanie Yasmin Brule, Derek J. Jonker, Christos S. Karapetis et al. · European Journal of Cancer · 2015 · 337 citations

Medicine, Oncology, Surgery +13

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers

Oliver Klein, Damien Kee, Adnan Nagrial et al. · JAMA Oncology · 2020 · 229 citations · Full text

Medicine, Oncology, Pharmacotherapy +15